Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Nuvolone

Showing results (31-40 of 115) with videos related to

Pageof 12
Sort By:
Blood Advances|September 4, 2020
Sequential response-driven bortezomib-based therapy followed by autologous stem cell transplant in AL amyloidosisMarco Basset, Paolo Milani, Mario Nuvolone, et al.
The American Journal of Pathology|March 5, 2013
Efficient amyloid A clearance in the absence of immunoglobulins and complement factorsJana Sponarova, Mario Nuvolone, Charlotte Whicher, et al.
European Heart Journal. Imaging Methods and Practice|June 17, 2026
Unveiling the unseen: navigating heart involvement in amyloidosis with biomarkers beyond the horizons of imagingGiuseppe Damiano Sanna, Paolo Milani, Valeria Anna Di Simone, et al.
Plos Pathogens|December 16, 2014
The role of the NADPH oxidase NOX2 in prion pathogenesisSilvia Sorce, Mario Nuvolone, Annika Keller, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Patterns of relapse after upfront bortezomib therapy in AL amyloidosisMarco Basset, Paolo Milani, Francesca Russo, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Patients with AL amyloidosis and low free light-chain burden have distinct clinical features and outcomePaolo Milani, Marco Basset, Francesca Russo, et al.
EMBO Molecular Medicine|July 29, 2010
Prion protein and Abeta-related synaptic toxicity impairmentAnna Maria Calella, Mélissa Farinelli, Mario Nuvolone, et al.
NPJ Vaccines|December 9, 2024
Publisher Correction: The dengue-specific immune response and antibody identification with machine learningEriberto Noel Natali, Alexander Horst, Patrick Meier, et al.
Blood Cancer Journal|September 3, 2020
Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapyPaolo Milani, Marco Basset, Mario Nuvolone, et al.
Annals of Medicine|April 26, 2007
The workings of the amyloid diseasesVittorio Bellotti, Mario Nuvolone, Sofia Giorgetti, et al.
Pageof 12

Showing results (31-40 of 115) with videos related to

Sort By:
Pageof 12
Blood Advances|September 4, 2020
Sequential response-driven bortezomib-based therapy followed by autologous stem cell transplant in AL amyloidosisMarco Basset, Paolo Milani, Mario Nuvolone, et al.
The American Journal of Pathology|March 5, 2013
Efficient amyloid A clearance in the absence of immunoglobulins and complement factorsJana Sponarova, Mario Nuvolone, Charlotte Whicher, et al.
European Heart Journal. Imaging Methods and Practice|June 17, 2026
Unveiling the unseen: navigating heart involvement in amyloidosis with biomarkers beyond the horizons of imagingGiuseppe Damiano Sanna, Paolo Milani, Valeria Anna Di Simone, et al.
Plos Pathogens|December 16, 2014
The role of the NADPH oxidase NOX2 in prion pathogenesisSilvia Sorce, Mario Nuvolone, Annika Keller, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Patterns of relapse after upfront bortezomib therapy in AL amyloidosisMarco Basset, Paolo Milani, Francesca Russo, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Patients with AL amyloidosis and low free light-chain burden have distinct clinical features and outcomePaolo Milani, Marco Basset, Francesca Russo, et al.
EMBO Molecular Medicine|July 29, 2010
Prion protein and Abeta-related synaptic toxicity impairmentAnna Maria Calella, Mélissa Farinelli, Mario Nuvolone, et al.
NPJ Vaccines|December 9, 2024
Publisher Correction: The dengue-specific immune response and antibody identification with machine learningEriberto Noel Natali, Alexander Horst, Patrick Meier, et al.
Blood Cancer Journal|September 3, 2020
Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapyPaolo Milani, Marco Basset, Mario Nuvolone, et al.
Annals of Medicine|April 26, 2007
The workings of the amyloid diseasesVittorio Bellotti, Mario Nuvolone, Sofia Giorgetti, et al.
Pageof 12